Skip to content
PeptideAgent

Telehealth providers in Oregon

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Oregon. What Oregon requires of telehealth prescribers and pharmacies, plus verified listings.

Oregon at a glance

Pharmacy regulator
Oregon Board of Pharmacy
503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Oregon

No verified telehealth providers serving Oregon are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Oregon

The Oregon Medical Board requires a physician who provides telemedicine to a patient located in Oregon to hold an Oregon license (or qualify for a narrow exception), to establish a physician-patient relationship, and to meet the same standard of care as in-person practice. The rules bar prescribing based solely on an online questionnaire without an adequate evaluation, but they do not require a prior in-person visit for non-controlled drugs, so a GLP-1 or compounded peptide prescription can be issued from a telemedicine visit. Oregon's payment parity statute (ORS 743A.058) defines telemedicine broadly, and the Medical Board treats asynchronous store-and-forward as telemedicine when it supports an adequate evaluation. Oregon is not a member of the Interstate Medical Licensure Compact; instead, OAR 847-025 lets an out-of-state physician hold an Oregon license for the practice of medicine across state lines. Peptides in this database are not controlled substances, so federal Ryan Haight limits do not apply. [2] [3] [4] [11]

Compounded GLP-1 access in Oregon

Telehealth GLP-1 patients should confirm the dispensing pharmacy appears in the Board of Pharmacy license lookup. [1] [9]

Research use only sellers in Oregon

ORS chapter 689 restricts dispensing of prescription drugs to registered pharmacies and licensed practitioners, and a seller of "research use only" injectable peptides to Oregon consumers is not a registered drug outlet. Oregon's Unlawful Trade Practices Act (ORS 646.608) also reaches misleading health claims made to consumers. [5] [10]

How to check a telehealth provider in Oregon

  1. Confirm the prescriber is licensed or registered to treat patients located in Oregon; the telehealth rules above explain what Oregon requires. [2] [3] [4] [11]
  2. Ask which pharmacy will fill the prescription and check it in the Oregon Board of Pharmacy license lookup. [1] [5] [6] [7] [8]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Oregon. [5] [10]

Common questions in Oregon

Can an out-of-state telehealth doctor treat me in Oregon?

Only if the physician holds a full Oregon license or an Oregon license for the practice of medicine across state lines under OAR 847-025. Oregon is not a member of the Interstate Medical Licensure Compact, so a compact license does not cover Oregon patients. Look the prescriber up in the Oregon Medical Board license search before paying. [2] [3] [11]

All peptide legal questions for Oregon

Sources

  1. [1]Oregon Board of Pharmacy
  2. [2]Oregon Medical Board (license search and board policies)
  3. [3]Oregon Administrative Rules chapter 847, division 25, Licensure to Practice Medicine Across State Lines (Oregon Medical Board)
  4. [4]ORS 743A.058, Telemedicine coverage and definitions
  5. [5]ORS chapter 689, Pharmacists; Drug Outlets; Drug Sales
  6. [6]Oregon Administrative Rule 855-041-1060, Non-Resident Pharmacies
  7. [7]Oregon Administrative Rules chapter 855, division 183, Drug Compounding (Oregon Board of Pharmacy, effective June 17, 2026)
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts
  11. [11]Interstate Medical Licensure Compact Commission: participating states